This inventor holds 7 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Lyvgen Biopharma Holdings Limited, Cccc National Engineering Research Center of Dredging Technology and Equipment Co., Ltd., Lyvgen Biopharma (Suzhou) Co., Ltd.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 6 
1 out of 2 
1 out of 1 
Years Active: 2021-2026
Title: Yi Wu: Innovator in Immunotherapy
Introduction
Yi Wu is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of immunotherapy. With a total of four patents to his name, he has made remarkable strides in enhancing immune responses through innovative antibody therapies.
Latest Patents
Among his latest patents are the "Anti-CD40 antibodies and uses thereof," which disclose agnostic anti-CD40 antibodies and methods for eliciting CD40 signaling. This advancement aims to enhance immune responses, particularly in dendritic cell functions, and offers potential treatments for diseases such as cancer and immune disorders. Another notable patent is the "Anti-CD137 antibodies and uses thereof," which presents agonistic anti-CD137 antibodies and methods for eliciting CD137 signaling. This innovation also focuses on enhancing immune responses, specifically T cell functions, and provides therapeutic avenues for cancer and immune disorders.
Career Highlights
Yi Wu has worked with notable companies in the biopharmaceutical sector, including Lyvgen Biopharma Holdings Limited and Lyvgen Biopharma Co., Ltd. His work in these organizations has been pivotal in advancing research and development in immunotherapy.
Collaborations
Some of his coworkers include Jieyi Wang and Yun Long, who have collaborated with him on various projects, contributing to the success of his innovative endeavors.
Conclusion
Yi Wu's contributions to immunotherapy through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for new treatments that could significantly impact the management of cancer and immune disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile